lysophosphatidic acid has been researched along with Diabetic Glomerulosclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jun, HS; Kim, D; Nam, GY; Seo, E | 1 |
| Cheon, J; Jun, HS; Kim, D; Lee, GH | 1 |
| Ban, KY; Jun, HS; Kim, D; Lee, GH | 1 |
| Hirata, T; Miyata, N; Roman, RJ; Smith, SV; Takahashi, T | 1 |
| Bascands, JL; Bertrand-Michel, J; Dupuy, A; Feigerlova, E; Gourdy, P; Guerci, B; Hadjadj, S; Halimi, JM; Roussel, R; Saulnier-Blache, JS; Schanstra, JP | 1 |
| Choi, H; Jun, HS; Kim, D; Lee, JH; Sarker, MK; Shin, D | 1 |
| Jun, HS; Kim, D; Lee, JH; Oh, YS | 1 |
| Choi, JW; Jun, HS; Jung, JY; Li, HY; Oh, YS | 1 |
1 review(s) available for lysophosphatidic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Lysophosphatidic Acid Signaling in Diabetic Nephropathy.
Topics: Animals; Diabetic Nephropathies; Humans; Lysophospholipids; Renal Insufficiency, Chronic; Signal Transduction | 2019 |
7 other study(ies) available for lysophosphatidic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Diabetic Nephropathies; Down-Regulation; Female; Fibronectins; Fibrosis; Lysophospholipids; Male; Mesangial Cells; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TNF Receptor-Associated Factor 4; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Ubiquitination | 2022 |
Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
Topics: Actins; Animals; Cadherins; Diabetic Nephropathies; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Factor V; Fibronectins; Fibrosis; Glycerophospholipids; Isoxazoles; JNK Mitogen-Activated Protein Kinases; Kidney Tubules; Kruppel-Like Transcription Factors; Lysophospholipids; Mice; Propionates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Transcription Factors; Vimentin | 2022 |
Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Early Growth Response Protein 1; Enhancer of Zeste Homolog 2 Protein; Histones; Inflammasomes; Inflammation; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Pyroptosis | 2023 |
Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.
Topics: Animals; Diabetic Nephropathies; Fibrosis; Hypertension, Renal; Isoxazoles; Kidney; Lysophospholipids; Male; Propionates; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley | 2021 |
Urinary lysophopholipids are increased in diabetic patients with nephropathy.
Topics: Aged; Albuminuria; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Lysophosphatidylcholines; Lysophospholipids; Male; Middle Aged; Pilot Projects; Renal Elimination; Renal Insufficiency; Severity of Illness Index; Up-Regulation | 2017 |
Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Topics: Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Kidney Glomerulus; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Phenylacetates; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Transcription Factor RelA | 2019 |
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
Topics: Animals; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3 beta; Isoxazoles; Kidney Cortex; Lysophospholipids; Male; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Phosphorylation; Propionates; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Smad2 Protein; Smad3 Protein; Sterol Regulatory Element Binding Protein 1; Time Factors; Transfection; Transforming Growth Factor beta | 2017 |